Big Data in Biobanking towards targeted medicine
|
|
|
- Kelley Nathaniel Blake
- 8 years ago
- Views:
Transcription
1 Big Data in Biobanking towards targeted medicine Ronald Stolk Professor Clinical Epidemiology, UMCG Board member Parelsnoer Institute Chief Scientific Officer LifeLines
2 What is a biobank? Systematic collection of biomaterials and associated clinical data Examples: population & hospital studies, clinical records (EHR, HIS) Biobank is Big Data for Health
3 Biobank is Big Data Registry (~ Gb/person) Genomic, proteomic Repeated measurements over time Linkage with GP, hospital, national registries Biorepository (~ /person) Different types of samples Small aliquots Multiple sampling
4 Why biobanks Better scientific research (quality and efficiency) To improve health care of future patients Valuable infrastructure Attractive for sponsors and granting agencies Facilitate international cooperation Attractive for research talents Competitive advantage
5 Why large biobanks Future of medicine is Personalized Health Care Focuses on individuals Personalized care, prevention, diagnosis Translate epidemiological associations at group level into individual risk estimates Combination of multiple risk factors Multi morbidity everybody is unique Large number of participants Homogeneous subgroups Rare risk factors
6 Dutch biobanks Biobank infrastructures by NFU BBMRI-NL: collaboration between all Dutch biobanks, part of BBMRI-EU Parelsnoer Institute: federated clinical biobank in all UMCs LifeLines: large population based biobank in the Northern provinces of the Netherlands
7 Why would you use Big Data for Health, available in biobanks? Cost effective use of data Less burden on participants / patients Enables novel research questions and innovation Creates bridges between disciplines by integration of data on various dimensions Opportunities for data validation
8 Big Data for Health: what is needed? Privacy, data security, data ownership Data storage, processing, quality Public trust: Who is going to use the data? How to arrange data access while privacy is protected? How to ensure that data benefits general public? Needed: Good governance Independent organization Expertise and knowledge
9
10 Connecting Dutch clinical biobanks Parelsnoer Institute: PSI Hereditary colorectal cancer Diabetes Rheumatoid arthritis and arthrosis Neurodegenerative disease Diseases Leukemia, myeloma and lymphoma Inflammatory bowel disease Etc. Cerebrovascular accident
11 PSI: design Patient COLLECT STORE USE In each UMC data collection and storage of samples Data extraction and transfer to Central Infrastructure Storage and dashboard Procedure of delivery of data and materials after medical ethical approval Research Pearl X among others SPSS On behalf of the Pearls University Medical Centers (UMCs) collect clinical data and biomaterials Biobanks in each UMC Central storage of data Biomaterials remain in each UMC biobank Data and biomaterials are available for research purposes: by the Pearls, other researchers within the UMCs and other parties Images center PSI METC-approval Harmonized SOP s Data definition Framework regulations
12 PSI output 14 disease areas ( pearls ) 8 UMCs, with affiliated hospitals ~22,000 patients ~50,000 samples >10 grant applications 5 real PSI publications Available on PSI website
13 PSI lessons learned It is possible to work together as UMC s Joint data collection, storage, usage, publications Core business of UMC more tightly linked: care and research on the same patient Input for research questions originate from care Results from research more easily fed back to care Standardisation of work flow for research benefits standard of care Input for new EHR s
14 What is LifeLines? LifeLines Cohort & Biorepository 167,729 participants at least 30 years follow-up Three generation design Northern region NL 10 LifeLines locations within the region
15 Baseline data collection Participants visit LifeLines Research Site Two visits of in total 70 minutes» Second visit fasting Content» Clinical measurements» Biomaterial collection At home» Feces, 24h urine collection» Questionnaires
16 Follow-up protocol Questionnaires Follow-up visit Link with external data (registries)» General Practitioners, hospital, Dutch Cancer Registry, Enrichment of LifeLines» Data and samples collected in add-on studies» Linkage with environmental data
17 Output >200 requests for data, biomaterials and for additional data collection approved by the LifeLines scientific board» internal medicine, genetics, epidemiology, environmental studies, nutrition, sociology, demography, economics Currently >60 researchers have data access Baseline paper Int J Epidemiol 2014 >30 publications in GWAS consortia >25 real LifeLines publications» Available on LifeLines website
18 BiKE Biobanking/cohort Knowledge and Expertise center Collaboration UMCG and LifeLines» Clinical and population based expertise Expertise» Study design/biobank setup» Big Data management (next generation sequencing, imaging)» Biomaterials processing and storage Services» Data analysis» Teaching and training
19
20 Big Data in Biobanking Now it gets more efficient to use existing biobanking projects with huge data and samples, rather than initiating new studies Big Data in Health are needed for Personalized (targeted) Medicine Infrastructures are available PSI, LifeLines, others
21 Available for you today: Data, samples Online catalogues Add-on studies New pearls PSI Additional questionnaires Additional assessments Infrastructure Expertise Public and private partners
22
23 Please visit our booths: PSI #5 LifeLines #
LifeLines Cohort Study. Salome Scholtens, Manager Research Office
LifeLines Cohort Study Salome Scholtens, Manager Research Office What is LifeLines? Biobank» LifeLines Cohort & Biorepository 165,000 participants at least 30 years follow-up Three generation design Northern
University Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
NGS and complex genetics
NGS and complex genetics Robert Kraaij Genetic Laboratory Department of Internal Medicine r.kraaij@erasmusmc.nl Gene Hunting Rotterdam Study and GWAS Next Generation Sequencing Gene Hunting Mendelian gene
Research Masters. Apply before June! Graduate School of Medical Sciences
Research Masters Graduate School of Medical Sciences Small-scaled for excellent students & design your own PhD project! Clinical and Psychosocial Epidemiology Medical and Pharmaceutical Drug Innovation
LifeLines for Researchers
LifeLines for Researchers A unique resource of data, samples and expertise www.lifelines.net www.lifelines.nl Hanneke Jansen MD/PhD, investigated the level of HbA1c in the blood of 2,921 non-diabetic adults.
Big Data for Population Health
Big Data for Population Health Prof Martin Landray Nuffield Department of Population Health Deputy Director, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery University of Oxford
Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future
Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future Daniel Masys, MD Professor and Chair Department of Biomedical Informatics Professor of Medicine Vanderbilt
Ethical, Legal and Societal consideration in the design of Canadian Longitudinal Study on Aging (CLSA) Parminder Raina, Susan Kirkland and Christina
Ethical, Legal and Societal consideration in the design of Canadian Longitudinal Study on Aging (CLSA) Parminder Raina, Susan Kirkland and Christina Wolfson McMaster University BCNAR Vancouver February
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
VICTORIAN CARDIAC OUTCOMES REGISTRY. Data Management Policy
VICTORIAN CARDIAC OUTCOMES REGISTRY Data Management Policy Version 1.0 26 February 2014 Table of Contents 1. Document Version Control... 1 1. Preface... 2 2. Project Information... 2 2.1 Purpose of VCOR...
Ethical and Public Health Implications of Genomic and Personalised Medicine. Dr Ingrid Slade
Ethical and Public Health Implications of Genomic and Personalised Medicine Dr Ingrid Slade Ethical and Public Health Implications of Genomic and Personalised Medicine What is personalised medicine and
Large Danish birth cohorts -- what have we learned?
Large Danish birth cohorts -- what have we learned? Opportunities and collaboration Ellen Aagaard Nøhr Professor & midwife Dep. D Gynaecology & Obstetrics eanohr@health.sdu.dk European Birth Cohorts: size
Medical research and data sharing how open can we be? Dr Renate Gertz AHRC Centre School of Law University of Edinburgh Scotland
Medical research and data sharing how open can we be? Dr Renate Gertz AHRC Centre School of Law University of Edinburgh Scotland Introduction The uses of health data Primary uses: For clinical care (relatively
The M.U.R.D.O.C.K. Study
1 The M.U.R.D.O.C.K. Study Measurement to Understand Reclassification of Disease Of Cabarrus/Kannapolis Jessica Tenenbaum, PhD and many, many others 2 MURDOCK Study Measurement to Understand the Reclassification
Dutch medical research and clinical data infrastructure coordinated by NFU. Morris Swertz, Richard Sinke, Marc Rietveld and many others.
Dutch medical research and clinical data infrastructure coordinated by NFU Morris Swertz, Richard Sinke, Marc Rietveld and many others. Outline NFU Towards program research data infrastructure VKGL Towards
making a difference where health matters Canadian Primary Care Sentinel Surveillance Network
making a difference where health matters Canadian Primary Care Sentinel Surveillance Network Copyright Notice January 20, 2015: Except where otherwise noted, all material contained in this publication,
EHRs and large scale comparative effectiveness research
EHRs and large scale comparative effectiveness research September 16, 2014 Dana C. Crawford, PhD Associate Professor Epidemiology and Biostatistics Institute for Computational Biology Single Nucleotide
The Blood Donor BIOBANK
The Blood Donor BIOBANK the first successful combination of blood donation and biobanking for medical research 1 1 Zoglmeier et al., TRANSFUSION 2011, 51(5): 1121-1122 Dr. Franz Weinauer SWISSTRANSFUSION
mycees De Patiënt In Zijn Data-web
mycees De Patiënt In Zijn -web Slide 1 Carelliance Vision Peter Walgemoed started Carelliance in 2000 with the vision to help care and research institutes manage their data as assets and use them with
The Contribution of large Healthcare Systems to Improving Treatment for Patients with Rare Diseases
Uniting Rare Diseases Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories and Clinical Data Keynote address: The Contribution of large Healthcare Systems to
Comprehensive Sample Management Solutions
Comprehensive Sample Management Solutions Discover the Hidden Value in Your Sample Assets solutions consulting sample storage sample bioprocessing onsite/offsite operations management logistics/relocation
Clinical Research from EHR data
Clinical Research from EHR data Gunnar O Klein professor in Health Informatics at NSEP Norwegian Centre for EHR Research Workshop at HelseIT in Trondheim 2012-09-19 1 Purpose of the workshop Together with
IT Help Desk Engineer / Audio Visual Technician
Position description IT Help Desk Engineer / Audio Visual Technician Position title: Help Desk / Audio Visual Engineer Division/Department: Information Technology Services Position reference: WEHI/CAHD
BioGrid s use of Business Analytics for Collaborative Medical Research. Maureen Turner, CEO, BioGrid Australia
BioGrid s use of Business Analytics for Collaborative Medical Research Maureen Turner, CEO, BioGrid Australia Overview Data sharing considerations BioGrid a collaborative model Data ethics, privacy, security
ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH
22 nd Annual Health Care Systems Research Network (HCSRN) Conference (formerly HMO Research Network Conference) ADVANCING POPULATION HEALTH: NEW MODELS AND THE ROLE OF RESEARCH Hosted by: Marshfield Clinic
Proposed Data Collection Submitted for Public Comment and. AGENCY: Centers for Disease Control and Prevention (CDC),
This document is scheduled to be published in the Federal Register on 02/01/2016 and available online at http://federalregister.gov/a/2016-01723, and on FDsys.gov BILLING CODE: 4163-18-P DEPARTMENT OF
BBMRI-NL awards thirty-four Complementation projects
Hub Hub is the official newsletter of BBMRI-NL The concept behind BBMRI-NL s Complementation projects remains the same: small-scale projects, improving the accessibility of existing biobanks for biomedical
EHR Databases and Their Role in Health & Innovation
8. New approaches to promoting innovation 8.4 Real-life data and learning from practice to advance innovation See Background Paper 8.4 (BP8_4Data.pdf) The costs of pharmaceutical R&D are high, with clinical
Section 8» Incidence, Mortality, Survival and Prevalence
Section 8» Incidence, Mortality, Survival and Prevalence 8.1. Description of Statistics Reported This section focuses on the regional distribution of cancer with data derived from the BC Cancer Registry
Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects
Report on the Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects Background and Goals of the Workshop June 5 6, 2012 The use of genome sequencing in human research is growing
Linking biobanks to registries: Why and how? Anne Barton
Linking biobanks to registries: Why and how? Anne Barton Biobanks why should we collect samples? Anti-TNF treatment in RA Cost approx. 8,000/person/year 30-40% RA patients do not respond Rare, serious
How Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
Healthcare Professional. Driving to the Future 11 March 7, 2011
Clinical Analytics for the Practicing Healthcare Professional Driving to the Future 11 March 7, 2011 Michael O. Bice Agenda Clinical informatics as context for clinical analytics Uniqueness of medical
INFORMATION LEAFLET. If anything is not clear, or if you would like more information, please
BIO INFOBK 1492 0410:Layout 1 21/04/2010 15:24 Page 1 INFORMATION LEAFLET You are being invited to take part in a major medical research project called UK Biobank. The purpose of UK Biobank is to set up
IDB Jointly surveilling diseases in the Caribbean
IDB Jointly surveilling diseases in the Caribbean Organization(s): Ministries of Health of The Bahamas, Barbados, Belize, Guyana, Jamaica and Trinidad and Tobago. The strategic partners accompanying the
Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit
Informatics: Opportunities & Applications Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit Routine Data "routine data" is data collected as byproducts of clinical
The NeurOmics team at a recent project meeting
Introduction Welcome to the NeurOmics project newsletter. This is the second edition and comes after the project has been underway for just over a year. This means that whilst we still have lots of work
TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES
CALL TEXT TO THE JOINT TRANSNATIONAL CALL 2015 FOR EPIGENOMICS OF COMPLEX DISEASES Submission deadline of proposals: 30 th of January 2015 at 01 p.m. CET (Paris, Berlin local time) Link to Call for Proposals
Masters of Science in Nursing Curriculum Guide Course Descriptions
Masters of Science in Nursing Curriculum Guide Course Descriptions Core Courses (26 credits total) N502 Theoretical Foundations of Nursing Practice (3 credits) Theoretical Foundations of Nursing Practice
Genomic medicine in Australia. Professor Warwick Anderson Chief Executive Officer National Health and Medical Research Council
Genomic medicine in Australia Professor Warwick Anderson Chief Executive Officer National Health and Medical Research Council This presentation 1. NHMRC s role funding research and translation 2. Genetic/genomic
Dundee e-health Centre of Excellence
Dundee e-health Centre of Excellence 1 Arthritis Research UK, British Heart Foundation Cancer Research UK Economic and Social Research Council Engineering and Physical Sciences Research Council National
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
1. WHY ARE ELECTRONIC MEDICAL RECORDS IMPORTANT FOR PERSONALIZED MEDICINE?
THE ELECTRONIC MEDICAL RECORD: A CRITICAL ISSUE IN PERSONALIZED MEDICINE 1. WHY ARE ELECTRONIC MEDICAL RECORDS IMPORTANT FOR PERSONALIZED MEDICINE? As initially configured, electronic medical records (EMRs)
Funding Privacy Commissioner of Canada: Secondary use of data from the EHR current governance challenges & potential approaches
Don Willison, Sc.D. Senior Scientist, Ontario Agency for Health Protection and Promotion Associate Professor, Part time, Clinical Epidemiology & Biostatistics, McMaster University don.willision@oahpp.ca
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
Big Data for Population Health and Personalised Medicine through EMR Linkages
Big Data for Population Health and Personalised Medicine through EMR Linkages Zheng-Ming CHEN Professor of Epidemiology Nuffield Dept. of Population Health, University of Oxford Big Data for Health Policy
EURORDIS-NORD-CORD Joint Declaration of. 10 Key Principles for. Rare Disease Patient Registries
EURORDIS-NORD-CORD Joint Declaration of 10 Key Principles for Rare Disease Patient Registries 1. Patient Registries should be recognised as a global priority in the field of Rare Diseases. 2. Rare Disease
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine
Proposal to Establish the Crohn s and Colitis Center at the University of Miami Miller School of Medicine Contents Mission... 1 Background... 2 Services and Programs... 2 Clinical Care... 2 IBD Specialists...
How Big Data is Shaping Health Care Decisions Pat Keran Sr. Director of Innovation Optum Technologies
How Big Data is Shaping Health Care Decisions Pat Keran Sr. Director of Innovation Optum Technologies Cancer is second only to heart disease as the most common cause of death in the U.S. Thanks By 2030,
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease
Opportunities for advancing biomarkers for patient stratification and early diagnosis in liver disease 80 Liver Disease and Obesity Liver disease biomarkers: Percent of adult population (United States)
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010
Genetic Alliance BioBank: A Virtual Tour of Registry Solutions to Accelerate Research February 22, 2010 Liz Horn Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1872/geneticalliancebiobank:avirtualto
Session 5 Panel Discussion
Session 5 Panel Discussion Question: How can epidemiology help integrate knowledge from basic, clinical and population sciences to accelerate translation from research to practice? Moderator: Muin J. Khoury,
Wilson Disease Research and Care. Looking Forward Ann Arbor, Michigan September 6, 2014 Fred Askari MD, PhD
Wilson Disease Research and Care Looking Forward Ann Arbor, Michigan September 6, 2014 Fred Askari MD, PhD The Future is Bright Improved Access to Care Improved Diagnostics Earlier Diagnosis New Treatments
LITERATURE REVIEW ON EPIDEMIOLOGICAL STUDIES LINKING EXPOSURE TO PESTICIDES AND HEALTH EFFECTS
LITERATURE REVIEW ON EPIDEMIOLOGICAL STUDIES LINKING EXPOSURE TO PESTICIDES AND HEALTH EFFECTS Dr Ioanna Tzoulaki Assistant Professor in Epidemiology MRC-PHE Centre for Environment and Health, Imperial
OFFICIALLY ON PAPER SUPREME COUNCIL OF HEALTH REPORT 2014
OFFICIALLY ON PAPER EVERY YEAR SUPREME COUNCIL OF HEALTH ISSUES AN ANNUAL REPORT PROVIDING AN UPDATE ON THE REFORMS BEING UNDERTAKEN BY THE COUNCIL AND ALL PARTNERS. Qatar s Supreme Council of Health was
The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Norway
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Norway Question 1: What laws or regulations apply to an application for conducting a clinical
DTL AS CROSS-SECTOR TECHNOLOGY PLATFORM
DTL AS CROSS-SECTOR TECHNOLOGY PLATFORM Enabling next generation life science research workshop Utrecht, October 23, 2013 AN INTEGRATED APPROACH TO BIG SCIENCE & DATA genomics/ngs proteomics metabolomics
Use advanced techniques for summary and visualization of complex data for exploratory analysis and presentation.
MS Biostatistics MS Biostatistics Competencies Study Development: Work collaboratively with biomedical or public health researchers and PhD biostatisticians, as necessary, to provide biostatistical expertise
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
Blood Biobanking Chances and Risks. The Bavarian Red Cross Blood Donor Biobank
Blood Biobanking Chances and Risks The Bavarian Red Cross Blood Donor Biobank EORTC-NCI-ASCO Meeting - November 2007 Outline Types of biobanking Why blood biobanking? Why blood banks? Why the Bavarian
Legal perspectives in EU projects. Prof. Dr. Nikolaus Forgó Leibniz University Hannover nikolaus.forgo@iri.unihannover.de
Legal perspectives in EU projects Prof. Dr. Nikolaus Forgó Leibniz University Hannover nikolaus.forgo@iri.unihannover.de Why a lawyer? A Confession 3 4 5 Background ACGT (Advancing Clinico Genomic Trials
SAP Healthcare Analytics Solutions Provide physicians and researchers access to patient data from various systems in realtime
SAP Healthcare Analytics Solutions Provide physicians and researchers access to patient data from various systems in realtime Stephan Schindewolf, SAP SE, July 13, 2015 Facts per Decision Need Decision
Exchange studies in Public Health Science
Exchange studies in Public Health Science 2013-2014 Exchange studies in Public Health Sciences Full programme information Public health scientists work with the prevention of disease and the promotion
How To Become A Biobanker
IV ESBB Annual Meetin Leipzig, October, 201 Manuel M Morente Spanish National Cancer Research Centre CNIO Spanish National Biobank Network Biobanker Where biobankers comes from We need to prepare a new
No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY, HEALTH AND CONSUMER AFFAIRS COUNCIL MEETING ON 9 AND 10 JUNE 2008
COUNCIL OF THE EUROPEAN UNION Brussels, 22 May 2008 9636/08 SAN 87 NOTE from: Committee of Permanent Representatives (Part 1) to: Council No. prev. doc.: 8770/08 SAN 64 Subject: EMPLOYMENT, SOCIAL POLICY,
NOW!! Registry and BioBank Services for! Your Organization/Company/Clinic/Project!
NOW!! Registry and BioBank Services for! Your Organization/Company/Clinic/Project! What Does Genetic Alliance Registry and BioBank Offer?! Flexible, customizable, registry and biobank options One-on-one
The 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
National Nursing Informatics Deep Dive Program
National Nursing Informatics Deep Dive Program What is Nursing Informatics and Why is it Important? Connie White Delaney, PhD, RN, FAAN, FACMI Dean and Professor, School of Nursing Director, Clinical and
Data modelling methods in clinical trials: Experiences from the CTMND project (ctmnd.org)
Data modelling methods in clinical trials: Experiences from the CTMND project (ctmnd.org) Athanasios Anastasiou, Emmanuel Ifeachor, John Zajicek & the CTMND Consortium University of Plymouth Peninsula
Centre for Biomarker Research in Medicine. COMET Competence Centre for Excellent Technologies
Centre for Biomarker Research in Medicine COMET Competence Centre for Excellent Technologies Why Biomarker Research? early diagnosis, often before manifestation identification of at-risk patients for new
Comprehensive Data Resource Introduction
National Cancer Institute U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Comprehensive Data Resource Introduction Helen Moore and Ping Guan Biorepositories and Biospecimen Research
REGULATIONS FOR THE POSTGRADUATE CERTIFICATE IN PUBLIC HEALTH (PCPH) (Subject to approval)
512 REGULATIONS FOR THE POSTGRADUATE CERTIFICATE IN PUBLIC HEALTH (PCPH) (Subject to approval) (See also General Regulations) M.113 Admission requirements To be eligible for admission to the programme
Taking Part in Research at University Hospitals Birmingham
University Hospitals Birmingham NHS Foundation Trust The Trust provides free monthly health talks on a variety of medical conditions and treatments. For more information visit www.uhb.nhs.uk or call 0121
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices. Response from Cancer Research UK to the Commission August 2010
Revision of the Directive 98/79/EC on In Vitro Diagnostic Medical Devices Response from Cancer Research UK to the Commission August 2010 1. Cancer Research UK (CR-UK) 1 is leading the world in finding
End of Life Care in Dutch Nursing Homes: Dying with Dignity?
EAPC Trondheim session End of life care and quality of death End of Life Care in Dutch Nursing Homes: Dying with Dignity? Prof dr Luc Deliens 1/2 Professor of Public Health and Palliative Care 1. Palliative
Measuring patient experiences in the Netherlands. Diana Delnoij OECD, Paris 17 November 2011
Measuring patient experiences in the Netherlands Diana Delnoij OECD, Paris 17 November 2011 Overview of the presentation Dutch system for measuring patient experiences Principles of patient experience
Adult-Gerontology Acute Care Nurse Practitioner Program BS/MS Seamless DNP Program Plan Summer 2016
SEE REVERSE SIDE FOR POLICY & STUDENT AGREEMENT N8102 Advanced Pharmacology 3 Didactic N8786 Advanced Clinical Assessment Across the Lifespan 3 Didactic Fall 2016 N6838 Diagnosis and Management of the
Clinicians and patients needs and expectations from registries
Clinicians and patients needs and expectations from registries Luciano Vittozzi cnmr.eu@iss.it National Centre Rare Diseases National Institute for Health Rome Italy EPIRARE is a project co-funded by the
Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS): DATA AND SAMPLE ACCESS AND OWNERSHIP POLICY February 2007
Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS): DATA AND SAMPLE ACCESS AND OWNERSHIP POLICY February 2007 1. Summary This paper covers the procedures that should be followed
Using Big Data to Advance Healthcare Gregory J. Moore MD, PhD February 4, 2014
Using Big Data to Advance Healthcare Gregory J. Moore MD, PhD February 4, 2014 Sequencing Technology - Hype Cycle (Gartner) Gartner - Hype Cycle for Healthcare Provider Applications, Analytics and Systems,
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy in Biochemistry FACULTY OF MEDICAL SCIENCE Naresuan University 73 Doctor of Philosophy in Biochemistry The Biochemistry Department at Naresuan University is a leader in lower northern
Updating Rheumatology Skills in Primary Care: The Maine Arthritis Partnership (MAP) Program
Updating Rheumatology Skills in Primary Care: The Maine Arthritis Partnership (MAP) Program Advisory Board Jacqueline B. Cawley, DO; Sr. Director for Ambulatory Care and Preventive Health, MaineHealth
FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies
FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies Raymond A. Huml, MS, DVM, RAC Executive Director, Head, Global Biosimilars Business Development and Strategic Planning, Quintiles
How To Understand The Relationship Between Genetics And Environment
Different Pathomechanisms for Asthma and Allergies (NEJM 363:121ff) Genetics of Complex Diseases Unraveled by Combining GWAS and Metabolomics (Nature Genetics 42:137. PLoS Genetics 4:1) Disease Management
Mary B Codd. MD, MPH, PhD, FFPHMI UCD School of Public Health, Physiotherapy & Pop. Sciences
HRB / CSTAR Grant Applications Training Day Convention Centre Dublin, 9 th September 2010 Key Elements of a Research Protocol Mary B Codd. MD, MPH, PhD, FFPHMI UCD School of Public Health, Physiotherapy
AAMC Project to Document the Effects of HIPAA on Research
AAMC Project to Document the Effects of HIPAA on Research Susan H. Ehringhaus, J.D. Associate General Counsel Association of American Medical Colleges ACE Annual Meeting, Sept. 13, 2004 AAMC HIPAA Survey
www.ontariohealthstudy.ca
OAHPP Grand Round The Ontario Health Study February 2011 Lyle Palmer, Executive Scientific Director www.ontariohealthstudy.ca What is the OHS? A large population-based, longitudinal cohort study Prospective
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
SURE: Helping to get the most out of routinely collected data
SURE: Helping to get the most out of routinely collected data Registry Special Interest Group Meeting 9 October 2015 Outline 1. The role of the Sax Institute 2. Why SURE was developed 3. How SURE is being
What you should know about Data Quality. A guide for health and social care staff
What you should know about Data Quality A guide for health and social care staff Please note the scope of this document is to provide a broad overview of data quality issues around personal health information
SEQUENCING INITIATIVE SUOMI (SISU) SYMPOSIUM SPEAKERS August 26, 2014
SEQUENCING INITIATIVE SUOMI (SISU) SYMPOSIUM SPEAKERS August 26, 2014 Professor Aarno Palotie Professor Aarno Palotie is the Research Director of the Human Genomics program at the Finnish Institute for
A leader in the development and application of information technology to prevent and treat disease.
A leader in the development and application of information technology to prevent and treat disease. About MOLECULAR HEALTH Molecular Health was founded in 2004 with the vision of changing healthcare. Today
Strategy and pilot phase for patient registries
Strategy and pilot phase for patient registries Draft still under discussion Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015 Xavier Kurz, Head of Monitoring
ACRONIM : InNerMeD-I-Network. STARTING DATE: 2013-04-01 DURATION (in months): 30. PRIORITY AREA: Actions under the second objective 'Promote health'
IInherriitted NeuRoMettabolliic Diiseases IINFORMATIION NETWORK ACRONIM : InNerMeD-I-Network STARTING DATE: 2013-04-01 DURATION (in months): 30 PRIORITY AREA: Actions under the second objective 'Promote
Inventory Patient Registries in the Netherlands
Inventory Patient Registries in the Netherlands DANS (M. Grootveld, M. Polhout, H. Tjalsma) Mondriaan (S. Visser, W. De Bruijn) RIVM (R. Nugteren, M. Weda) NIVEL (R. Verheij, L. Van Dijk) 1 ISBN:978-94-6122-158-2
The new European clinical trials regulation Dr. N.Gökbuget
The new European clinical trials regulation Dr. N.Gökbuget Head of Study Center Department of Medicine II and Goethe University Cancer Center Frankfurt, Germany European Leukemia Net: Major Aim to Foster
Translational research facilitating experimental medicine in dementia in the UK
Translational research facilitating experimental medicine in dementia in the UK Simon Lovestone Director Biomedical Research Unit for dementia at Maudsley and King s Route Map for Dementia Research June
Global Policy on Interactions with Healthcare Professionals
Global Policy on Interactions with Healthcare Professionals Global Policy on Interactions with Healthcare Professionals Pfizer is committed to collaborating with physicians and other healthcare professionals,
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours: